114 related articles for article (PubMed ID: 16448619)
1. Analysis of RNA-protein interactions by a microplate-based fluorescence anisotropy assay.
Mao C; Flavin KG; Wang S; Dodson R; Ross J; Shapiro DJ
Anal Biochem; 2006 Mar; 350(2):222-32. PubMed ID: 16448619
[TBL] [Abstract][Full Text] [Related]
2. Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.
Cunningham KS; Dodson RE; Nagel MA; Shapiro DJ; Schoenberg DR
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12498-502. PubMed ID: 11050168
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.
Goolsby KM; Shapiro DJ
Nucleic Acids Res; 2003 Oct; 31(19):5644-53. PubMed ID: 14500828
[TBL] [Abstract][Full Text] [Related]
4. Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3'-untranslated region-binding protein.
Dodson RE; Shapiro DJ
J Biol Chem; 1997 May; 272(19):12249-52. PubMed ID: 9139664
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction.
Rensburg GV; Mackedenski S; Lee CH
PLoS One; 2017; 12(2):e0171196. PubMed ID: 28182633
[TBL] [Abstract][Full Text] [Related]
6. In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain protein.
Kanamori H; Dodson RE; Shapiro DJ
Mol Cell Biol; 1998 Jul; 18(7):3991-4003. PubMed ID: 9632784
[TBL] [Abstract][Full Text] [Related]
7. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
[TBL] [Abstract][Full Text] [Related]
8. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
Sparanese D; Lee CH
Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
Coulis CM; Lee C; Nardone V; Prokipcak RD
Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
[TBL] [Abstract][Full Text] [Related]
10. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
[TBL] [Abstract][Full Text] [Related]
11. Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.
King DT; Barnes M; Thomsen D; Lee CH
PLoS One; 2014; 9(3):e91585. PubMed ID: 24622399
[TBL] [Abstract][Full Text] [Related]
12. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
[TBL] [Abstract][Full Text] [Related]
13. Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.
Tilloy-Ellul A; Raffalli-Mathieu F; Lang MA
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):695-703. PubMed ID: 10215609
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
Lemm I; Ross J
Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
[TBL] [Abstract][Full Text] [Related]
15. High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
Mahapatra L; Mao C; Andruska N; Zhang C; Shapiro DJ
J Biomol Screen; 2014 Mar; 19(3):427-36. PubMed ID: 24108120
[TBL] [Abstract][Full Text] [Related]
16. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
[TBL] [Abstract][Full Text] [Related]
17. Identification of a 43-kDa protein in human liver cytosol that binds to the 3'-untranslated region of CYP2A6 mRNA.
Gilmore J; Rotondo F; Pelletier AM; LaMarre J; Alaoui-Jamali M; Kirby GM
Biochem Pharmacol; 2001 Sep; 62(6):669-78. PubMed ID: 11551511
[TBL] [Abstract][Full Text] [Related]
18. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.
Weidensdorfer D; Stöhr N; Baude A; Lederer M; Köhn M; Schierhorn A; Buchmeier S; Wahle E; Hüttelmaier S
RNA; 2009 Jan; 15(1):104-15. PubMed ID: 19029303
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
[TBL] [Abstract][Full Text] [Related]
20. Drosophila vigilin, DDP1, localises to the cytoplasm and associates to the rough endoplasmic reticulum.
Batlle M; Marsellach FX; Huertas D; Azorín F
Biochim Biophys Acta; 2011 Jan; 1809(1):46-55. PubMed ID: 21035573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
